Literature DB >> 11430596

A role for secondary V(D)J recombination in oncogenic chromosomal translocations?

M Davila1, S Foster, G Kelsoe, K Yang.   

Abstract

Chromosomal translocations are hallmarks of certain lymphoproliferative disorders. Indeed, in many leukemias and lymphomas, translocations are the transforming event that brings about malignancy. Recurrence of the immunoglobulin (Ig) and T-cell receptor (Tcr) loci at the breakpoints of oncogenic chromosomal translocations has led to speculation that the lymphocyte-specific process of V(D)J rearrangement, which is necessary for the generation of functional Ig and TCR antigen receptors on B and T lymphocytes, mediates translocation. Recent studies have led to a fuller understanding of the molecular mechanisms of V(D)J rearrangement and have revealed that the V(D)J recombinase possesses latent transposase activity. These studies have led to plausible models of illegitimate V(D)J recombination producing chromosomal translocations consistent with those present in lymphomas and leukemias. Errors of V(D)J recombination may even generate lymphomas with the phenotypes of mature cells. For example, follicular and Burkitt's lymphomas have been classified by phenotype and somatic genotype as malignant germinal center (GC) B or post-GC B cells. The GC is a site of affinity maturation where B cells undergo V(D)J hypermutation and Ig class switch; in addition, much evidence has accumulated to suggest that GC B cells may also support secondary V(D)J recombination. Interestingly, all three of these elements, genomic plasticity, mutation, and translocation breakpoints near switch sites or recombinational elements, are characteristic of certain lymphomas. The high frequency of lymphomas carrying these GC markers suggests that the GC reaction may play a significant role in lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430596     DOI: 10.1016/s0065-230x(01)81002-2

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  7 in total

1.  In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.

Authors:  Terri L Messier; J Patrick O'Neill; Sai-Mei Hou; Janice A Nicklas; Barry A Finette
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

2.  Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling.

Authors:  Lindsay G Cowell; Marco Davila; Kaiyong Yang; Thomas B Kepler; Garnett Kelsoe
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

Review 3.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

4.  Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice.

Authors:  Roman A Timakhov; Yinfei Tan; Mamta Rao; Zemin Liu; Deborah A Altomare; Jianming Pei; David L Wiest; Olga O Favorova; Janice E Knepper; Joseph R Testa
Journal:  Genes Chromosomes Cancer       Date:  2009-09       Impact factor: 5.006

Review 5.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

6.  Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cells.

Authors:  Anne E Lieberman; Masayuki Kuraoka; Marco Davila; Garnett Kelsoe; Lindsay G Cowell
Journal:  BMC Immunol       Date:  2009-06-25       Impact factor: 3.615

7.  Identification and utilization of arbitrary correlations in models of recombination signal sequences.

Authors:  Lindsay G Cowell; Marco Davila; Thomas B Kepler; Garnett Kelsoe
Journal:  Genome Biol       Date:  2002-11-21       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.